D910L00001 (MERMAID-1): A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Study to Determine the Efficacy of Adjuvant Durvalumab in Combination with Platinum-based Chemotherapy in Completely Resected Stage II-III NSCLC

Objective

Clinical Trial Details >>

Principal Investigator(s)

Benjamin Solomon, MD

Clinical Trial Categories

• Lung Cancer

Contact

Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org